By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Research Digest > Data & Numbers > Influenza dominates African respiratory surveillance; SARS-CoV-2 remains low
Data & NumbersResearch Digest

Influenza dominates African respiratory surveillance; SARS-CoV-2 remains low

GMJ
Last updated: 25/05/2026 18:28
By
GMJ Research Desk
Share
8 Min Read
Bar chart showing influenza subtypes detected in African surveillance week 19
Influenza testing in 13 African countries during week 19 (May 4–10, 2026) revealed a 9% positivity rate driven by A and B subtypes, while SARS-CoV-2 remained at 2%, signalling a sustained shift toward endemic influenza dominance and COVID-19 control across the region. — Photo: Denis Ngai / Pexels
SHARE
🎧 Listen to this article3:52 min · 559 words · GMJ Audio

Updated 25/05/2026

Contents
      • Influenza subtypes detected across 13 African countries, week 19
  • Influenza A and B drive regional disease burden
  • SARS-CoV-2 positivity falls to 2% in acute surveillance
  • Laboratory capacity and regional participation strengthen surveillance
    • Key takeaways
  • Frequently asked questions
    • What does “subtyping not performed” mean for 36 influenza A specimens?
2 min read|449 words

During epidemiological week 19 (May 4–10, 2026), 13 countries across the WHO African Region reported respiratory virus surveillance data, revealing a 9% influenza positivity rate against a backdrop of minimal SARS-CoV-2 circulation. According to WHO African Region respiratory virus surveillance data, influenza A and B viruses dominated clinical respiratory specimens, while COVID-19 testing showed a sustained decline across the region.

9%
Influenza positivity rate among 951 tested specimens in WHO African Region, week 19 (May 4–10, 2026)

Influenza subtypes detected across 13 African countries, week 19

Distribution of 86 positive specimens by influenza type and subtype, May 4–10, 2026

Influenza A (subtyping not performed)
36
Influenza B (Victoria)
24
Influenza A (H3)
19
Influenza A (H1N1)pdm09
4
Influenza B (lineage undetermined)

3

Source: WHO African Region Respiratory Virus Surveillance, Week 19, 2026 | Georgian Medical Journal News

Submit Your Paper
GMJ_Submit_Banner

Influenza A and B drive regional disease burden

Among 86 confirmed influenza cases, WHO African Region surveillance data show that 59 specimens were influenza A and 27 were influenza B. Influenza A without full subtyping accounted for the largest group (36 specimens), followed by influenza B Victoria lineage (24 specimens) and influenza A H3 (19 specimens). Pandemic H1N1 (H1N1)pdm09 represented only 4 cases, with 3 influenza B viruses remaining untyped.

SARS-CoV-2 positivity falls to 2% in acute surveillance

In week 19, laboratories across the African Region processed 908 specimens for SARS-CoV-2, yielding only 18 positive cases—a 2% positivity rate, according to WHO African Region surveillance.

🎙️ Related Podcast Episodes
🎧 #23 | WHO: Next-Generation Influenza Vaccines Could Save Millions of Lives · 18m
🎧 #13 | Six Years After COVID-19: Is the World Better Prepared for the Next Pandemic? · 19m
🎧 # 6 | WHO Influenza Vaccine Update 2026–2027 | GMJ Briefing · 19m

Cumulatively from weeks 1 to 19, the influenza laboratory network tested 25,293 specimens for SARS-CoV-2, with 785 positive results—a cumulative positivity of 3.1%, according to WHO African Region surveillance data.

Laboratory capacity and regional participation strengthen surveillance

The week 19 surveillance snapshot represents data from 13 countries—Algeria, Burkina Faso, Cameroon, Ethiopia, Ghana, Kenya, Mali, Mauritania, Nigeria, Senegal, South Africa, Togo, and the United Republic of Tanzania, according to WHO African Region surveillance data. A total of 961 specimens were collected and processed, with 951 tested for influenza and 908 tested for SARS-CoV-2.

Influenza positivity reached 9% in week 19 across 13 African countries, with influenza A and B co-circulating, while SARS-CoV-2 remained at 2% positivity.

— WHO African Region Respiratory Virus Surveillance, Week 19 (May 2026)

Key takeaways

  • Influenza positivity of 9% (86 of 951 specimens) in week 19 across 13 African countries, according to WHO African Region surveillance data.
  • Influenza A H3 (19 cases) and influenza B Victoria (24 cases) were the most commonly detected subtypes, while pandemic H1N1 remained rare (4 cases), per WHO surveillance data.
  • SARS-CoV-2 positivity at 2% (18 of 908 specimens), with a cumulative year-to-date rate of 3.1%, according to WHO African Region surveillance.
  • Participation by 13 countries and 12 laboratories documented in WHO surveillance report.

Frequently asked questions

What does “subtyping not performed” mean for 36 influenza A specimens?

Subtyping identifies whether influenza A is H1N1, H3N2, or another subtype. When resources or time constraints prevent full characterization, specimens are reported as influenza A without subtype designation.

Source: Respiratory virus surveillance in the WHO African Region Epidemiological Week 19, May 4 to 10 2026

Was this article helpful?

Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →

Related Coverage

Weekly Dual-Hormone Injection Reduces Liver Fat by 67% in Obesity TrialJul 5, 2026
Defective HIV copies explain persistent viral traces in treated patients, new study revealsJul 5, 2026
Minocycline Stroke Trial Debate Highlights Neuroprotection Research ChallengesJul 5, 2026
First In Vivo CRISPR Gene Editing Treatment Shows Promise for Rare Blood DisorderJul 4, 2026
PG
Written by
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, GMJ News
Full profile →  ·  ORCID 0000-0001-7609-4515
Medical disclaimer. This article is health journalism intended for general information. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. Always seek your physician's advice regarding any medical condition.
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
Get the GMJ News digest
Evidence-based health journalism in your inbox. No spam; unsubscribe anytime.
TAGGED:epidemiologyinfluenzarespiratory surveillanceSARS-CoV-2WHO African Region
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByGMJ Research Desk
Follow:
GMJ Research Desk is part of GMJ News, the newsroom of the Georgian Medical Journal (gmj.ge), published by the Public Health Institute of Georgia. Every article is editorially reviewed before publication.
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Mobile Vascular Clinic Prevents Amputations Among Homeless Patients in Boston

Massachusetts General Hospital's mobile vascular clinic delivers specialized care directly to homeless…

Weekly Dual-Hormone Injection Reduces Liver Fat by 67% in Obesity Trial

Phase 3 trial shows weekly survodutide injections reduced liver fat by 67%…

Defective HIV copies explain persistent viral traces in treated patients, new study reveals

New research reveals that defective HIV copies, not infectious virus, explain most…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Chart comparing semaglutide and dulaglutide effectiveness in type 2 diabetes treatmentIllustrative image · Photo by Haberdoedas Photography on Pexels (Pexels License)
Clinical UpdatesNew StudiesPracticeResearch Digest

Weekly semaglutide outperforms dulaglutide for diabetes control in UK primary care study

By
GMJ Practice Desk
18/06/2026
Fluorescent microscopy image showing muscle cells with green nuclei and red membranes during fusion process
New Studies

Scientists Capture Muscle Cell Fusion in Real-Time for First Time

By
GMJ Research Desk
22/05/2026
Children laughing during therapeutic play session showing brain development benefits
New StudiesResearch Digest

Laughter Therapy Builds Brain Resilience in Children, New Research Shows

By
GMJ Research Desk
28/05/2026
Graph showing 14% of population has used AI instead of seeing a health provider
New Studies

One in seven people have turned to AI instead of visiting a health provider, major UK study reveals

By
GMJ Research Desk
20/05/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up